Innovita Biological Technology Co. Ltd. A Net Asset Quality Index
Innovita Biological Technology Co. Ltd. A net asset quality index. Innovita Biological Technology Co. Ltd. A (688253) has a Net Asset Quality Index of 93.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.23 Billion minus total liabilities of CN¥136.00 Million yields net assets of CN¥2.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Innovita Biological Technology Co. Ltd. shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Innovita Biological Technology Co. Ltd. A (2020–2025)
Net asset quality index of Innovita Biological Technology Co. Ltd. A from 2020 to 2025. This chart shows how Innovita Biological Technology Co. Ltd. A's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 93.9%, representing net assets of CN¥2.10 Billion against total assets of CN¥2.23 Billion CNY. Check 688253 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Innovita Biological Technology Co. Ltd. A Net Asset Quality Index by Year (2020–2025)
Innovita Biological Technology Co. Ltd. A net asset quality index by year from 2020 to 2025. The table below presents the year-by-year Net Asset Quality Index for Innovita Biological Technology Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688253 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.2% | CN¥2.05 Billion | CN¥2.28 Billion | CN¥223.32 Million | ▲ +0.1 pp |
| 2024 | 90.1% | CN¥1.99 Billion | CN¥2.21 Billion | CN¥219.07 Million | ▲ +0.9 pp |
| 2023 | 89.2% | CN¥1.84 Billion | CN¥2.07 Billion | CN¥223.65 Million | ▲ +2.2 pp |
| 2022 | 87.0% | CN¥1.69 Billion | CN¥1.94 Billion | CN¥253.24 Million | ▼ -5.6 pp |
| 2021 | 92.5% | CN¥738.17 Million | CN¥797.87 Million | CN¥59.70 Million | ▲ +7.1 pp |
| 2020 | 85.4% | CN¥668.01 Million | CN¥782.09 Million | CN¥114.08 Million | — |